BiotechTube
Home/Castle Biosciences/Derek Maetzold
DM

Derek Maetzold

Founder, President & CEO

Castle Biosciences

Therapeutic Areas

OncologyGastroenterologyDermatology

Castle Biosciences Pipeline

DrugIndicationPhase
DecisionDx-Melanoma (i31-SLNB)Cutaneous Melanoma (Stage I-III)Commercial/Ongoing Validation
DecisionDx-SCCCutaneous Squamous Cell CarcinomaCommercial/Ongoing Validation
DecisionDx-UM & PRAMEUveal MelanomaCommercial/Ongoing Validation
TissueCypherBarrett’s EsophagusCommercial/Ongoing Validation
MyPath MelanomaDifficult-to-Diagnose Melanocytic LesionsCommercial/Ongoing Validation
IDgenix (AdvanceAD Tx)Moderate-to-Severe Atopic DermatitisCommercial/Early Launch

Leadership Team at Castle Biosciences

FS
Frank Stokes
Chief Financial Officer
DO
Dana Oliver
Chief Commercial Officer
RC
Robert Cook
Chief Legal Officer & Corporate Secretary
ML
Matthew Leavitt, M.D.
Chief Medical Officer
View full Castle Biosciences profile